Ken Griffin's position in BridgeBio Pharma is currently worth $10.3 Million. That's 0.01% of their equity portfolio (1151st largest holding). The first BridgeBio Pharma trade was made in Q2 2019. Since then Ken Griffin bought shares 35 more times and sold shares on 21 occasions. The stake costed the investor $8.88 Million, netting the investor a gain of 15% so far.